生細胞イメージング市場規模、シェア、動向、2030年までの世界予測

世界の生細胞イメージング市場は2025年に31億3,000万米ドル規模となり、予測期間中に年平均成長率（CAGR）8.68%で成長し、2030年には47億5,000万米ドルに達するとMarketsandMarketでは予測しています。

イメージング技術の継続的な進歩と、世界的に増加する癌症例が、市場の成長を支える要因となっています。さらに、細胞生物学研究のための資金や助成金の利用可能性、創薬や研究におけるHCS技術の採用の増加も、生細胞イメージング製品および消耗品の需要を高め、市場の成長を後押ししています。主要企業は、生細胞イメージング分野における新たな成長機会を獲得するために新興市場への進出を拡大していますが、生細胞イメージング機器の高コストが、小規模な学術機関や製薬会社にとってこれらの製品を入手しにくくしているため、この拡大は制限されています。

MarketsandMarkets（マーケッツアンドマーケッツ）「生細胞イメージング市場 – 製品（機器、消耗品、ソフトウェア、サービス）、用途（細胞生物学、幹細胞、創薬）、技術（タイムラプス顕微鏡、FRET、FRAP、HCS）、エンドユーザー（製薬会社、バイオテクノロジー企業、CRO） – 2030年までの世界市場予測 – Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) – Global Forecast to 2030」は生細胞（ライブセルイメージング）市場を調査し、主要セグメント別に分析・予測を行っています。

調査対象セグメント

• オファリング別ライブセルイメージング市場
  • 機器
  • 消耗品
  • ソフトウェア
  • サービス
• 技術別ライブセルイメージング市場
• 用途別ライブセルイメージング市場
• エンドユーザ別ライブセルイメージング市場
• 地域別ライブセルイメージング市場

調査対象企業

• Danaher (US)
• Zeiss Group (Germany)
• Nikon Corporation (Japan)
• Evident (Japan)
• Revvity (US)
• Sartorius AG (Germany)
• Agilent Technologies, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• Nanoentek (Korea)
• Bruker (US)
• BD (US)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Tecan Trading AG (Switzerland)
• Corning Incorporated (US)
• Sysmex Corporation (Japan)
• Blue-Ray Biotech Corp. (Taiwan)
• Curiosis Inc. (South Korea)
• CYTENA GmbH (Germany)
• Abberior Instruments America LLC (Germany)
• Phase Holographic Imaging PHI AB (Sweden)
• Aligned Genetics (South Korea)
• Cherry Biotech (France)
• Nanolive SA (Switzerland)
• CytoTronics (US)
• Etaluma, Inc. (US)
• Axion BioSystems, Inc (US)
• TissueGnostics GmbH (Austria)

調査概要：

本レポートは、世界の生細胞イメージング市場の詳細な概観を提供します。提供製品、技術、アプリケーション、エンドユーザー、地域といった様々なセグメントにおける市場規模と将来の成長可能性を推定することを目的としています。レポートの範囲は、生細胞イメージング市場の成長に影響を与える主要な要因（推進要因、阻害要因、課題、機会など）に関する詳細な情報を網羅しています。主要な業界プレーヤーの詳細な分析を行い、事業概要、ソリューションとサービス、主要戦略、パートナーシップ、契約、製品およびサービスの発売、合併・買収、そして生細胞イメージング市場に関連する最近の動向に関する洞察を提供します。本レポートでは、生細胞イメージング市場のエコシステムにおける新興スタートアップの競合分析も行っています。

本レポートを購入する理由

本レポートは、生細胞イメージング市場全体および各サブセグメントの収益に関する最も正確な推定値を提供することで、市場リーダーおよび新規参入企業を支援します。本レポートは、関係者が競争環境を理解し、より深い洞察を得て、自社の事業をより有利な位置づけにし、適切な市場参入戦略を立案するのに役立ちます。また、市場の動向を把握し、主要な市場推進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します。

生細胞イメージング市場の成長に影響を与える主要な推進要因（創薬におけるハイスループットスクリーニング技術の普及拡大、がん罹患率の上昇、研究資金の増加、イメージング技術の進歩）、阻害要因（ハイスループットスクリーニングシステムの高コスト）、機会（新興市場における生細胞イメージング技術の普及拡大、個別化医療におけるHCSの応用）、および課題（細胞培養における細胞生存率と細胞環境の維持、画像解析とデータ管理）の分析

• 製品開発／イノベーション：新たに発売された製品およびサービスに関する詳細な洞察と、生細胞イメージング市場の技術評価
• 市場開発：有望な市場に関する包括的な情報 ― 本レポートは、様々な地域における生細胞イメージング市場を分析しています。
• 市場の多様化：生細胞イメージング市場における新製品・サービス、未開拓地域、最新動向、投資に関する包括的な情報
• 競合評価：主要プレーヤーの市場シェア、成長戦略、製品およびサービス提供に関する詳細な評価：Danaher（米国）、Zeiss Group（ドイツ）、Nikon Corporation（日本）、Evident（日本）、Revvity（米国）、Sartorius AG（ドイツ）、Agilent Technologies, Inc.（米国）、Thermo Fisher Scientific Inc.（米国）、Nanoentek（韓国）、Bruker（米国）、BD（米国）、Merck KGaA（ドイツ）、Bio-Rad Laboratories, Inc.（米国）、Tecan Trading AG（スイス）、Corning Incorporated（米国）、Sysmex Corporation（日本）、Blue-Ray Biotech Corp.（台湾）、Curiosis Inc.（韓国）、CYTENA GmbH（ドイツ）、Abberior Instruments America LLC（ドイツ）、Phase Holographic Imaging PHI AB（スウェーデン）、Aligned Genetics（韓国）、Cherry Biotech（フランス）、Nanolive SA市場には、スイスのCytoTronics、米国のEtaluma, Inc.、米国のAxion BioSystems, Inc、オーストリアのTissueGnostics GmbHなどが参入している。

Report Description

The global live cell imaging market is projected to reach USD 4.75 billion in 2030 from USD 3.13 billion in 2025, growing at a CAGR of 8.68% during the forecast period. Ongoing advancements in imaging technologies, along with the rising cancer cases in the world, are factors supporting the growth of the market. Moreover, the availability of funds and grants for cellular biology research and the growing adoption of HCS techniques for drug discovery and research is increasing the demand for live cell imaging products and consumables, supporting the growth of the market. Key players are expanding their reach in emerging markets to grab new growth opportunities in the field of live cell imaging; however, this expansion is restricted due to the high cost of live cell imaging instruments, making these products inaccessible to small academic institutes and pharmaceutical companies.

The market for live cell imaging and analysis software is expected to witness the highest growth within the offerings segment during the forecast period.

The live cell imaging software market is expected to witness the highest growth during the forecast period within the offering segment. This high growth can be attributed to the growing demand for advanced data analysis, automation, and AI integration in cellular research. As imaging technologies become more advanced, researchers require powerful software tools to manage large volumes of complex image data, perform real-time analysis, and extract meaningful biological insights. The growing adoption of high-content screening, 3D imaging, and time-lapse microscopy further fuels the need for intelligent software capable of handling multi-dimensional datasets. In addition, the integration of machine learning and deep learning algorithms into imaging software is enabling faster and more accurate cell segmentation, tracking, and phenotyping, making these tools essential in drug discovery, cancer research, and regenerative medicine.

The pharmaceutical & biotechnology companies end user segment held the largest market share in the live cell imaging market, by end user, during the forecast period.

Pharmaceutical & biotechnology companies held the largest share of the live cell imaging market by end users in 2024. This large share can be attributed to the increasing demand for advanced imaging technologies in drug discovery, cell biology research, and personalized medicine. These companies heavily rely on live cell imaging to observe cellular behaviors, study disease mechanisms, and evaluate the effects of potential drug candidates in real time. The rise in the prevalence of chronic diseases and the growing need for precise therapies further fuel the adoption of live cell imaging technologies in these sectors. This trend is expected to continue during the forecast period of 2025-2030, driven by ongoing innovations in imaging technologies, the need for faster and more accurate drug development, and the growing importance of cellular research in therapeutic development.

Asia Pacific is expected to be the fastest-growing region in the live cell imaging market.

Asia Pacific is the fastest-growing region in the live cell imaging market, having the highest CAGR during the forecast period of 2025–2030. This growth is driven by increased investment in the healthcare and biotechnology sectors, along with the rising demand for advanced imaging technologies. China, Japan, and India are increasing their research and development activities, particularly in drug discovery and regenerative medicine, which require advanced imaging techniques. Additionally, government support for scientific research and the expanding focus on personalized medicine are key factors fueling this market growth in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
• By Designation: (Managers)- 45%, (CXOs, Directors)- 30%, and (Executives)- 25%
• By Region: North America- 40%, Europe- 25%, Asia Pacific- 20%, Rest of the World- 15%

List of Companies Profiled in the Report:

• Danaher (US)
• Zeiss Group (Germany)
• Nikon Corporation (Japan)
• Evident (Japan)
• Revvity (US)
• Sartorius AG (Germany)
• Agilent Technologies, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• Nanoentek (Korea)
• Bruker (US)
• BD (US)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Tecan Trading AG (Switzerland)
• Corning Incorporated (US)
• Sysmex Corporation (Japan)
• Blue-Ray Biotech Corp. (Taiwan)
• Curiosis Inc. (South Korea)
• CYTENA GmbH (Germany)
• Abberior Instruments America LLC (Germany)
• Phase Holographic Imaging PHI AB (Sweden)
• Aligned Genetics (South Korea)
• Cherry Biotech (France)
• Nanolive SA (Switzerland)
• CytoTronics (US)
• Etaluma, Inc. (US)
• Axion BioSystems, Inc (US)
• TissueGnostics GmbH (Austria)

Research Coverage:

This report provides a detailed picture of the global live cell imaging market. It aims to estimate the size and future growth potential of the market across different segments such as the offering, technology, application, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the live cell imaging market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services, key strategies, partnerships, agreements, product and service launches, mergers and acquisitions, and recent developments associated with the live cell imaging market. Competitive analysis of upcoming startups in the live cell imaging market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall live cell imaging market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (Growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, Growing availability of funds for research, advancement in imaging technology), restraints (High cost of high-content screening systems), opportunities (increasing adoption of live cell imaging technologies in emerging markets, and application of HCS in personalized medicine), and challenges (maintaining cell viability and cellular environment in cell cultures, and image analysis and data management) influencing the growth of the live cell imaging market

• Product Development/Innovation: Detailed insight into newly launched products & services and technological assessment of the live cell imaging market
• Market Development: Comprehensive information about lucrative markets – the report analyses the live cell imaging market across varied regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the live cell imaging market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products and service offerings of leading players Danaher (US), Zeiss Group (Germany), Nikon Corporation (Japan), Evident (Japan), Revvity (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Nanoentek (Korea), Bruker (US), BD (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Tecan Trading AG (Switzerland), Corning Incorporated (US), Sysmex Corporation (Japan), Blue-Ray Biotech Corp. (Taiwan), Curiosis Inc. (South Korea), CYTENA GmbH (Germany), Abberior Instruments America LLC (Germany), Phase Holographic Imaging PHI AB (Sweden), Aligned Genetics (South Korea), Cherry Biotech (France), Nanolive SA (Switzerland), CytoTronics (US), Etaluma, Inc. (US), Axion BioSystems, Inc (US), and TissueGnostics GmbH (Austria) among others in the market.

Table of Contents

1 INTRODUCTION 35

1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 36
1.3.2 INCLUSIONS AND EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 38
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 39

2 RESEARCH METHODOLOGY 40

2.1 RESEARCH DATA 40
2.1.1 SECONDARY DATA 40
2.1.2 PRIMARY DATA 41
2.2 MARKET SIZE ESTIMATION 43
2.2.1 INSIGHTS FROM PRIMARIES 45
2.2.2 TOP-DOWN APPROACH 46
2.3 GROWTH RATE FORECAST 47
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 49
2.5 RESEARCH ASSUMPTIONS 50
2.6 RESEARCH LIMITATIONS 50
2.7 RISK ASSESSMENT 51

3 EXECUTIVE SUMMARY 52

4 PREMIUM INSIGHTS 56

4.1 LIVE CELL IMAGING MARKET OVERVIEW 56
4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING AND COUNTRY, 2024 57
4.3 LIVE CELL IMAGING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 58
4.4 LIVE CELL IMAGING MARKET, BY END USER, 2024 58
4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59

5 MARKET OVERVIEW 60

5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
5.2.1 DRIVERS 61
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery 61
5.2.1.2 Rising incidence of cancer 62
5.2.1.3 Growing availability of research funds 63
5.2.1.4 Advancements in imaging technology 65
5.2.2 RESTRAINTS 66
5.2.2.1 Expensive high-content screening systems 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Increasing adoption of live cell imaging technologies in emerging markets 66
5.2.3.2 Growing applications of live cell imaging in personalized medicine 67
5.2.4 CHALLENGES 67
5.2.4.1 Maintenance of cell viability and cellular environment in cell cultures 67
5.2.4.2 Image analysis and data management 67
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68
5.4 PRICING ANALYSIS 68
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 69
5.4.2 AVERAGE SELLING PRICE, BY REGION 71
5.5 VALUE CHAIN ANALYSIS 73
5.6 ECOSYSTEM ANALYSIS 74
5.7 INVESTMENT AND FUNDING ACTIVITY 76
5.8 TECHNOLOGY ANALYSIS 77
5.8.1 KEY TECHNOLOGIES 77
5.8.1.1 Fluorescence microscopy 77
5.8.1.2 Confocal microscopy 77
5.8.1.3 Super-resolution microscopy 77
5.8.1.4 Förster resonance energy transfer 78
5.8.1.5 Fluorescence recovery after photobleaching 78
5.8.2 COMPLEMENTARY TECHNOLOGIES 78
5.8.2.1 Image analysis software 78
5.8.2.2 Microfluidics 79
5.8.2.3 Optogenetics 79
5.8.2.4 Multiphoton microscopy 79
5.8.3 ADJACENT TECHNOLOGIES 80
5.8.3.1 Fixed cell imaging 80
5.9 PATENT ANALYSIS 80

5.10 TRADE DATA ANALYSIS 84
5.10.1 IMPORT DATA FOR HS CODE 901120 84
5.10.2 EXPORT DATA FOR HS CODE 901120 85
5.11 KEY CONFERENCES AND EVENTS, 2025–2026 86
5.12 REGULATORY LANDSCAPE 87
5.12.1 REGULATORY FRAMEWORK 87
5.12.1.1 North America 87
5.12.1.1.1 US 87
5.12.1.1.2 Canada 88
5.12.1.2 Europe 88
5.12.1.2.1 UK 88
5.12.1.2.2 European Union 88
5.12.1.3 Asia Pacific 89
5.12.1.3.1 Japan 89
5.12.1.3.2 South Korea 89
5.12.1.3.3 China 89
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
5.13 PORTER’S FIVE FORCES ANALYSIS 91
5.13.1 THREAT FROM NEW ENTRANTS 92
5.13.2 THREAT FROM SUBSTITUTES 93
5.13.3 BARGAINING POWER OF SUPPLIERS 93
5.13.4 BARGAINING POWER OF BUYERS 93
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 93
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 94
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
5.14.2 BUYING CRITERIA 95
5.15 IMPACT OF AI/GENERATIVE AI ON LIVE CELL IMAGING MARKET 96
5.15.1 INTRODUCTION 96
5.15.2 KEY COMPANIES IMPLEMENTING AI 97
5.15.3 AI USE CASES 98
5.15.4 FUTURE OF AI IN LIVE CELL IMAGING ECOSYSTEM 98
5.16 IMPACT OF 2025 US TARIFF ON LIVE CELL IMAGING MARKET 99
5.16.1 INTRODUCTION 99
5.16.2 KEY TARIFF RATES 99
5.16.3 PRICE IMPACT ANALYSIS 101
5.16.4 IMPACT ON COUNTRY/REGION 101
5.16.4.1 US 101
5.16.4.2 Europe 102
5.16.4.3 Asia Pacific 103

5.16.5 IMPACT ON END-USE INDUSTRIES 103
5.16.5.1 Pharmaceutical & biotech companies 104
5.16.5.2 Academic & research institutes 104
5.16.5.3 Contract research organizations 105

6 LIVE CELL IMAGING MARKET, BY OFFERING 106

6.1 INTRODUCTION 107
6.2 PRODUCTS 107
6.2.1 INSTRUMENTS 107
6.2.1.1 Microscopes 112
6.2.1.1.1 Ongoing technological advancements in microscopes to support growth 112
6.2.1.2 Cell imaging systems 116
6.2.1.2.1 Seamless integration and workflow efficiency of standalone systems to boost market 116
6.2.1.3 Cell analyzers 120
6.2.1.3.1 Accuracy and reproducibility of cell analyzers to encourage growth 120
6.2.1.4 Accessories 123
6.2.1.4.1 Increasing demand for live cell imaging in life science research to accelerate growth 123
6.2.2 CONSUMABLES 127
6.2.2.1 Reagents 130
6.2.2.1.1 Widespread usage of reagents in life science research to foster growth 130
6.2.2.2 Assay kits 134
6.2.2.2.1 Higher customer convenience and time-saving solutions to amplify growth 134
6.2.2.3 Media 138
6.2.2.3.1 Increasing investments in cell-based research to intensify growth 138
6.2.2.4 Other consumables 141
6.3 SOFTWARE 145
6.3.1 INCREASING ADVANCEMENTS IN IMAGE ACQUISITION TO SUPPORT GROWTH 145
6.4 SERVICES 149
6.4.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO FUEL MARKET 149

7 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 152

7.1 INTRODUCTION 153
7.2 TIME-LAPSE MICROSCOPY 153
7.2.1 GROWING DEMAND FOR HIGH CONTENT AND HIGH THROUGHPUT ANALYSIS IN PRECLINICAL STUDIES TO DRIVE MARKET 153

7.3 FLUORESCENCE RESONANCE ENERGY TRANSFER 157
7.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST MARKET 157
7.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING 160
7.4.1 INCREASING ADVANCEMENTS IN FLUORESCENT PROTEINS TO SPUR GROWTH 160
7.5 HIGH-CONTENT SCREENING 164
7.5.1 GROWING FOCUS ON DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE MARKET 164
7.6 OTHER TECHNOLOGIES 167

8 LIVE CELL IMAGING MARKET, BY APPLICATION 171

8.1 INTRODUCTION 172
8.2 CELL BIOLOGY RESEARCH 172
8.2.1 INCREASING FOCUS ON DISEASE RESEARCH TO SUPPORT GROWTH 172
8.3 DRUG DISCOVERY 176
8.3.1 GROWING USE OF HIGH-CONTENT SCREENING CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO BOOST MARKET 176
8.4 STEM CELL RESEARCH 179
8.4.1 INCREASING FOCUS ON REGENERATIVE MEDICINE TO EXPEDITE GROWTH 179
8.5 DEVELOPMENTAL BIOLOGY 183
8.5.1 RISING INTEREST IN ORGANOGENESIS AND TISSUE MORPHOGENESIS TO PROMOTE GROWTH 183

9 LIVE CELL IMAGING MARKET, BY END USER 187

9.1 INTRODUCTION 188
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 188
9.2.1 INCREASING R&D ACTIVITIES TO DEVELOP NEW DRUGS TO SUPPORT GROWTH 188
9.3 ACADEMIC & RESEARCH INSTITUTES 192
9.3.1 RISING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO AID GROWTH 192
9.4 CONTRACT RESEARCH ORGANIZATIONS 195
9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE MARKET 195

10 LIVE CELL IMAGING MARKET, BY REGION 199

10.1 INTRODUCTION 200
10.2 NORTH AMERICA 200
10.2.1 MACROECONOMIC ANALYSIS FOR NORTH AMERICA 201
10.2.2 US 205
10.2.2.1 Presence of major players and increasing investments in life science research to sustain growth 205
10.2.3 CANADA 208
10.2.3.1 Government initiatives to promote research to aid growth 208
10.3 EUROPE 211
10.3.1 MACROECONOMIC ANALYSIS FOR EUROPE 212
10.3.2 GERMANY 215
10.3.2.1 Presence of large number of academic research institutes to boost market 215
10.3.3 UK 218
10.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to foster market 218
10.3.4 FRANCE 220
10.3.4.1 Booming pharmaceutical manufacturing industry to drive market growth 220
10.3.5 ITALY 223
10.3.5.1 Strong research tradition, government funding, and collaborative research networks to fuel growth 223
10.3.6 SPAIN 226
10.3.6.1 Rising R&D expenditure to boost market 226
10.3.7 REST OF EUROPE 228
10.4 ASIA PACIFIC 232
10.4.1 MACROECONOMIC ANALYSIS FOR ASIA PACIFIC 232
10.4.2 CHINA 237
10.4.2.1 Low manufacturing cost and surge in research & development investments to spur growth 237
10.4.3 JAPAN 240
10.4.3.1 Presence of large geriatric population and increasing research activities to bolster growth 240
10.4.4 INDIA 243
10.4.4.1 Growing pharmaceutical industry to propel market 243
10.4.5 SOUTH KOREA 246
10.4.5.1 Ongoing collaborations and research initiatives among market players to encourage growth 246
10.4.6 AUSTRALIA 249
10.4.6.1 Robust healthcare infrastructure to facilitate growth 249
10.4.7 REST OF ASIA PACIFIC 252
10.5 LATIN AMERICA 256
10.5.1 MACROECONOMIC ANALYSIS FOR LATIN AMERICA 256
10.5.2 BRAZIL 260
10.5.2.1 Growing focus on biotechnology and biomedical innovations to drive market 260
10.5.3 MEXICO 262
10.5.3.1 Low manufacturing cost and large population to support growth 262
10.5.4 REST OF LATIN AMERICA 265

10.6 MIDDLE EAST 268
10.6.1 MACROECONOMIC ANALYSIS FOR MIDDLE EAST 268
10.6.2 GCC COUNTRIES 272
10.6.2.1 Saudi Arabia 275
10.6.2.1.1 Increasing life science research funding to aid growth 275
10.6.2.2 UAE 278
10.6.2.2.1 Presence of research institutes supporting live cell imaging studies to foster growth 278
10.6.2.3 Rest of GCC Countries 280
10.6.3 REST OF MIDDLE EAST 283
10.7 AFRICA 286
10.7.1 GOVERNMENT INITIATIVES TO CONTRIBUTE TO GROWTH 286
10.7.2 MACROECONOMIC ANALYSIS FOR AFRICA 286

11 COMPETITIVE LANDSCAPE 290

11.1 INTRODUCTION 290
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 290
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET 291
11.3 REVENUE ANALYSIS, 2022–2024 293
11.4 MARKET SHARE ANALYSIS, 2024 294
11.5 COMPANY VALUATION AND FINANCIAL METRICS 297
11.6 BRAND/PRODUCT COMPARISON 298
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 299
11.7.1 STARS 299
11.7.2 EMERGING LEADERS 299
11.7.3 PERVASIVE PLAYERS 299
11.7.4 PARTICIPANTS 300
11.8 COMPANY FOOTPRINT, KEY PLAYERS, 2024 301
11.8.1 COMPANY FOOTPRINT 301
11.8.2 REGION FOOTPRINT 302
11.8.3 OFFERING FOOTPRINT 303
11.8.4 APPLICATION FOOTPRINT 305
11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 306
11.9.1 PROGRESSIVE COMPANIES 306
11.9.2 RESPONSIVE COMPANIES 306
11.9.3 DYNAMIC COMPANIES 306
11.9.4 STARTING BLOCKS 306
11.10 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 308
11.10.1 DETAILED LIST OF KEY STARTUPS/SMES 308
11.10.2 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309

11.11 COMPETITIVE SCENARIO 310
11.11.1 PRODUCT LAUNCHES AND UPGRADES 310
11.11.2 DEALS 311
11.11.3 EXPANSIONS 312

12 COMPANY PROFILE 313

12.1 KEY PLAYERS 313
12.1.1 DANAHER 313
12.1.1.1 Business overview 313
12.1.1.2 Products offered 314
12.1.1.3 Recent developments 316
12.1.1.3.1 Product launches and upgrades 316
12.1.1.3.2 Deals 316
12.1.1.4 MnM view 317
12.1.1.4.1 Key strengths 317
12.1.1.4.2 Strategic choices 317
12.1.1.4.3 Weaknesses and competitive threats 317
12.1.2 ZEISS GROUP 318
12.1.2.1 Business overview 318
12.1.2.2 Products offered 319
12.1.2.3 Recent developments 320
12.1.2.3.1 Product launches and upgrades 320
12.1.2.3.2 Deals 321
12.1.2.3.3 Expansions 321
12.1.2.4 MnM view 321
12.1.2.4.1 Key strengths 321
12.1.2.4.2 Strategic choices 322
12.1.2.4.3 Weaknesses and competitive threats 322
12.1.3 THERMO FISHER SCIENTIFIC INC. 323
12.1.3.1 Business overview 323
12.1.3.2 Products offered 324
12.1.3.3 Recent developments 325
12.1.3.3.1 Deals 325
12.1.3.4 MnM view 326
12.1.3.4.1 Key strengths 326
12.1.3.4.2 Strategic choices 326
12.1.3.4.3 Weaknesses and competitive threats 326
12.1.4 REVVITY 327
12.1.4.1 Business overview 327
12.1.4.2 Products offered 328
12.1.4.3 Recent developments 329
12.1.4.3.1 Product launches and upgrades 329
12.1.4.4 MnM view 330
12.1.4.4.1 Key strengths 330
12.1.4.4.2 Strategic choices 330
12.1.4.4.3 Weaknesses and competitive threats 330
12.1.5 SARTORIUS AG 331
12.1.5.1 Business overview 331
12.1.5.2 Products offered 332
12.1.5.3 Recent developments 333
12.1.5.3.1 Deals 333
12.1.5.4 MnM view 333
12.1.5.4.1 Key strength 333
12.1.5.4.2 Strategic choices 333
12.1.5.4.3 Weaknesses and competitive threats 333
12.1.6 NIKON CORPORATION 334
12.1.6.1 Business overview 334
12.1.6.2 Products offered 335
12.1.6.3 Recent developments 336
12.1.6.3.1 Expansions 336
12.1.7 EVIDENT 337
12.1.7.1 Business overview 337
12.1.7.2 Products offered 337
12.1.7.3 Recent developments 338
12.1.7.3.1 Product launches and upgrades 338
12.1.8 AGILENT TECHNOLOGIES, INC. 339
12.1.8.1 Business overview 339
12.1.8.2 Products offered 340
12.1.8.3 Recent developments 342
12.1.8.3.1 Product launches and upgrades 342
12.1.9 NANOENTEK 343
12.1.9.1 Business overview 343
12.1.9.2 Products offered 343
12.1.10 BRUKER 344
12.1.10.1 Business overview 344
12.1.10.2 Products offered 345
12.1.10.3 Recent developments 346
12.1.10.3.1 Deals 346
12.1.11 BD 347
12.1.11.1 Business overview 347
12.1.11.2 Products offered 348
12.1.12 MERCK KGAA 349
12.1.12.1 Business overview 349
12.1.12.2 Products offered 351
12.1.13 BIO-RAD LABORATORIES, INC. 352
12.1.13.1 Business overview 352
12.1.13.2 Products offered 353
12.1.14 TECAN TRADING AG 354
12.1.14.1 Business overview 354
12.1.15 SYSMEX CORPORATION 356
12.1.15.1 Business overview 356
12.1.15.2 Products offered 357
12.1.16 CORNING INCORPORATED 358
12.1.16.1 Business overview 358
12.1.16.2 Products offered 359
12.2 OTHER PLAYERS 360
12.2.1 AXION BIOSYSTEMS, INC. 360
12.2.2 BLUE-RAY BIOTECH CORP. 361
12.2.3 CURIOSIS INC. 361
12.2.4 CYTENA GMBH 362
12.2.5 ABBERIOR GMBH 363
12.2.6 PHASE HOLOGRAPHIC IMAGING PHI AB 364
12.2.7 ALIGNED GENETICS INC. 365
12.2.8 CHERRY BIOTECH 365
12.2.9 NANOLIVE SA 366
12.2.10 CYTOTRONICS 367
12.2.11 ETALUMA, INC. 368
12.2.12 TISSUEGNOSTICS GMBH 369
13 APPENDIX 370
13.1 DISCUSSION GUIDE 370
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 373
13.3 CUSTOMIZATION OPTIONS 375
13.4 RELATED REPORTS 375

13.5 AUTHOR DETAILS 376

LIST OF TABLES

TABLE 1 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 61
TABLE 2 ESTIMATED NEW CANCER CASES IN US, 2025 62
TABLE 3 AVERAGE SELLING PRICE TREND OF LIVE CELL IMAGING PRODUCTS,
BY KEY PLAYER, 2022–2024 69
TABLE 4 AVERAGE SELLING PRICE, BY REGION, 2024 72
TABLE 5 LIVE CELL IMAGING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 75
TABLE 6 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2025 80
TABLE 7 LIVE CELL IMAGING MARKET: PATENT ANALYSIS, 2024 82
TABLE 8 IMPORT DATA FOR LIVE CELL IMAGING PRODUCTS (HS CODE 901120),
BY COUNTRY, 2020–2024 (USD THOUSAND) 84
TABLE 9 EXPORT DATA FOR HS CODE 901120, BY COUNTRY,
2020–2024 (USD THOUSAND) 85
TABLE 10 LIVE CELL IMAGING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 86
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 15 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 92
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 94
TABLE 17 BUYING CRITERIA, BY END USER 95
TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES 99
TABLE 19 LIVE CELL IMAGING PRODUCT-RELATED TARIFF REVISION 100
TABLE 20 IMPACT OF US TARIFF ON END-USE APPLICATIONS OF LIVE CELL IMAGING PRODUCTS 103
TABLE 21 LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 107
TABLE 22 INSTRUMENTS OFFERED BY KEY MARKET PLAYERS 108
TABLE 23 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 24 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 25 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 26 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 27 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 28 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION,
2023–2030 (USD MILLION) 111
TABLE 29 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 30 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 112
TABLE 31 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 32 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 33 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES,
BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 34 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES,
BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 35 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 36 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 37 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 38 CELL IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 116
TABLE 39 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS,
BY REGION, 2023–2030 (USD MILLION) 117
TABLE 40 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 41 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 42 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 43 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 44 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 119
TABLE 45 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 46 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS 120
TABLE 47 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 48 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 49 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS,
BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 50 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 51 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 52 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023–2030 (USD MILLION) 122
TABLE 53 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 54 ACCESSORIES OFFERED BY KEY MARKET PLAYERS 123
TABLE 55 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 56 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 57 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES,
BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 58 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES,
BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 59 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 60 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES,
BY REGION, 2023–2030 (USD MILLION) 126
TABLE 61 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 62 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION,
2023–2030 (USD MILLION) 127
TABLE 63 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 64 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 65 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 66 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 67 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION,
2023–2030 (USD MILLION) 129
TABLE 68 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 69 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 130
TABLE 70 REAGENTS OFFERED BY KEY MARKET PLAYERS 131
TABLE 71 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION,
2023–2030 (USD MILLION) 131
TABLE 72 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 73 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 74 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 75 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 76 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY REGION, 2023–2030 (USD MILLION) 133
TABLE 77 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 78 ASSAY KITS OFFERED BY KEY MARKET PLAYERS 134
TABLE 79 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION,
2023–2030 (USD MILLION) 135
TABLE 80 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 81 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,
BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 82 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLE MARKET FOR ASSAY KITS,
BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 83 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 84 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,
BY REGION, 2023–2030 (USD MILLION) 137
TABLE 85 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 86 MEDIA OFFERED BY KEY MARKET PLAYERS 138
TABLE 87 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION,
2023–2030 (USD MILLION) 138
TABLE 88 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 89 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 90 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 91 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 92 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY REGION, 2023–2030 (USD MILLION) 140
TABLE 93 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLE MARKET FOR MEDIA,
BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 94 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS 142
TABLE 95 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION,
2023–2030 (USD MILLION) 142
TABLE 96 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 97 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 98 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 99 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 100 MIDDLE EAST: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 101 GCC COUNTRIES: OTHER LIVE CELL IMAGING CONSUMABLES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 102 SOFTWARE OFFERED BY KEY MARKET PLAYERS 145
TABLE 103 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 146
TABLE 104 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 146
TABLE 105 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 147
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 147
TABLE 107 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 148
TABLE 108 MIDDLE EAST: LIVE CELL IMAGING SOFTWARE MARKET, BY REGION,
2023–2030 (USD MILLION) 148
TABLE 109 GCC COUNTRIES: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 148
TABLE 110 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 149
TABLE 111 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 149
TABLE 112 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 150
TABLE 113 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 150
TABLE 114 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 151
TABLE 115 MIDDLE EAST: LIVE CELL IMAGING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 151
TABLE 116 GCC COUNTRIES: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 151
TABLE 117 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 153
TABLE 118 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION,
2023–2030 (USD MILLION) 154
TABLE 119 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 120 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 121 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 122 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 123 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY REGION, 2023–2030 (USD MILLION) 156
TABLE 124 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 125 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 157
TABLE 126 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 127 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 128 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 129 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 130 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 159
TABLE 131 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 132 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 161
TABLE 133 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 161
TABLE 134 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 162
TABLE 135 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 136 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 163
TABLE 137 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 163
TABLE 138 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 163
TABLE 139 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION,
2023–2030 (USD MILLION) 164
TABLE 140 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 141 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 142 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 143 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 144 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY REGION, 2023–2030 (USD MILLION) 166
TABLE 145 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 146 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2023–2030 (USD MILLION) 168
TABLE 147 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 148 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 149 ASIA PACIFIC: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 150 LATIN AMERICA: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 151 MIDDLE EAST: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY REGION, 2023–2030 (USD MILLION) 170
TABLE 152 GCC COUNTRIES: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 153 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172
TABLE 154 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY REGION,
2023–2030 (USD MILLION) 173
TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 156 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 157 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 158 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 159 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY REGION, 2023–2030 (USD MILLION) 175
TABLE 160 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 161 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION,
2023–2030 (USD MILLION) 176
TABLE 162 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 163 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 164 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 165 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 166 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION, 2023–2030 (USD MILLION) 178
TABLE 167 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 168 LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY REGION,
2023–2030 (USD MILLION) 180
TABLE 169 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 180
TABLE 170 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 171 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 172 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 173 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY REGION, 2023–2030 (USD MILLION) 182
TABLE 174 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 175 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION,
2023–2030 (USD MILLION) 183
TABLE 176 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 177 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 178 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 179 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 180 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY REGION, 2023–2030 (USD MILLION) 185
TABLE 181 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 186
TABLE 182 LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 188
TABLE 183 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 189
TABLE 184 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 189
TABLE 185 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 186 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 187 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 191
TABLE 188 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 191
TABLE 189 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 191
TABLE 190 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023–2030 (USD MILLION) 192
TABLE 191 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 192 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 193 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 194 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 195 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 194
TABLE 196 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195
TABLE 197 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2023–2030 (USD MILLION) 196
TABLE 198 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 196
TABLE 199 EUROPE: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 197
TABLE 200 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 197
TABLE 201 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 198
TABLE 202 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION) 198
TABLE 203 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 198
TABLE 204 LIVE CELL IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 200
TABLE 205 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 202
TABLE 206 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 203
TABLE 207 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 208 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 209 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 204
TABLE 210 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 204
TABLE 211 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 205
TABLE 212 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 205
TABLE 213 US: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 206
TABLE 214 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 215 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 207
TABLE 216 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 207
TABLE 217 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 208
TABLE 218 US: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 208
TABLE 219 CANADA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 209
TABLE 220 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 221 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 222 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 210
TABLE 223 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 211
TABLE 224 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 211
TABLE 225 EUROPE: KEY MACROECONOMIC INDICATORS 212
TABLE 226 EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 213
TABLE 227 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 228 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 229 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 214
TABLE 230 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 214
TABLE 231 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 214
TABLE 232 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 215
TABLE 233 GERMANY: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 216
TABLE 234 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 235 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 236 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 217
TABLE 237 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 217
TABLE 238 GERMANY: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 217
TABLE 239 UK: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 218
TABLE 240 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 241 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 242 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 219
TABLE 243 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 220
TABLE 244 UK: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 220
TABLE 245 FRANCE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 221
TABLE 246 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 247 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 222
TABLE 248 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 222
TABLE 249 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 223
TABLE 250 FRANCE: LIVE CEL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 223
TABLE 251 ITALY: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 224
TABLE 252 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 224
TABLE 253 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 224
TABLE 254 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225
TABLE 255 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 225
TABLE 256 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 225
TABLE 257 SPAIN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 226
TABLE 258 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 259 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 260 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 227
TABLE 261 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 228
TABLE 262 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 228
TABLE 263 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 229
TABLE 264 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 229
TABLE 265 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 230
TABLE 266 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 230
TABLE 267 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 231
TABLE 268 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 231
TABLE 269 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 233
TABLE 270 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 235
TABLE 271 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 272 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 273 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 236
TABLE 274 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 236
TABLE 275 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 237
TABLE 276 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 237
TABLE 277 CHINA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 238
TABLE 278 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 279 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 280 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239
TABLE 281 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 240
TABLE 282 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 240
TABLE 283 JAPAN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 241
TABLE 284 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 285 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 286 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 242
TABLE 287 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 243
TABLE 288 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 243
TABLE 289 INDIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 244
TABLE 290 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 291 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 245
TABLE 292 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245
TABLE 293 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 246
TABLE 294 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 246
TABLE 295 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 247
TABLE 296 SOUTH KOREA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 297 SOUTH KOREA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 298 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 248
TABLE 299 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 249
TABLE 300 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 249
TABLE 301 AUSTRALIA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 250
TABLE 302 AUSTRALIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 303 AUSTRALIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 304 AUSTRALIA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 251
TABLE 305 AUSTRALIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 252
TABLE 306 AUSTRALIA: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 252
TABLE 307 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 253
TABLE 308 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 309 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 310 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 254
TABLE 311 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 255
TABLE 312 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 255
TABLE 313 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 257
TABLE 314 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 257
TABLE 315 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 316 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 258
TABLE 317 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 258
TABLE 318 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 259
TABLE 319 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 259
TABLE 320 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 259
TABLE 321 BRAZIL: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 260
TABLE 322 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 323 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 324 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 261
TABLE 325 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 262
TABLE 326 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 262
TABLE 327 MEXICO: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 263
TABLE 328 MEXICO: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE,
2023–2030 (USD MILLION) 263
TABLE 329 MEXICO: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 263
TABLE 330 MEXICO: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 264
TABLE 331 MEXICO: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 264
TABLE 332 MEXICO: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 264
TABLE 333 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 265
TABLE 334 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 335 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 336 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 266
TABLE 337 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 267
TABLE 338 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 267
TABLE 339 MIDDLE EAST: KEY MACROECONOMIC INDICATORS 269
TABLE 340 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 269
TABLE 341 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 269
TABLE 342 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 343 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 270
TABLE 344 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 271
TABLE 345 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 271
TABLE 346 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY REGION,
2023–2030 (USD MILLION) 271
TABLE 347 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 272
TABLE 348 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 272
TABLE 349 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 273
TABLE 350 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 273
TABLE 351 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 274
TABLE 352 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 274
TABLE 353 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 275
TABLE 354 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 275
TABLE 355 SAUDI ARABIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 276
TABLE 356 SAUDI ARABIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 276
TABLE 357 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 277
TABLE 358 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 277
TABLE 359 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 278
TABLE 360 UAE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 278
TABLE 361 UAE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 279
TABLE 362 UAE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 279
TABLE 363 UAE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 279
TABLE 364 UAE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 280
TABLE 365 UAE: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 280
TABLE 366 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 281
TABLE 367 REST OF GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 368 REST OF GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 369 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 282
TABLE 370 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 282
TABLE 371 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 283
TABLE 372 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING,
2023–2030 (USD MILLION) 283
TABLE 373 REST OF MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284
TABLE 374 REST OF MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284
TABLE 375 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 285
TABLE 376 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 285
TABLE 377 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 286
TABLE 378 AFRICA: KEY MACROECONOMIC INDICATORS 287
TABLE 379 AFRICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 287
TABLE 380 AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 381 AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 382 AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 288
TABLE 383 AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 289
TABLE 384 AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 289
TABLE 385 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET, 2022–2025 291
TABLE 386 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION 295
TABLE 387 LIVE CELL IMAGING MARKET: REGION FOOTPRINT 302
TABLE 388 LIVE CELL IMAGING MARKET: OFFERING FOOTPRINT 303
TABLE 389 LIVE CELL IMAGING MARKET: APPLICATION FOOTPRINT 305
TABLE 390 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 308
TABLE 391 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309
TABLE 392 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES AND UPGRADES,
JANUARY 2022–APRIL 2025 310
TABLE 393 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2022–APRIL 2025 311
TABLE 394 LIVE CELL IMAGING MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025 312
TABLE 395 DANAHER: COMPANY OVERVIEW 313
TABLE 396 DANAHER: PRODUCTS OFFERED 314
TABLE 397 DANAHER: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 316
TABLE 398 DANAHER: DEALS, JANUARY 2022–APRIL 2025 316
TABLE 399 ZEISS GROUP: COMPANY OVERVIEW 318
TABLE 400 ZEISS GROUP: PRODUCTS OFFERED 319
TABLE 401 ZEISS GROUP: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 320
TABLE 402 ZEISS GROUP: DEALS, JANUARY 2022–APRIL 2025 321
TABLE 403 ZEISS GROUP: EXPANSIONS, JANUARY 2022–APRIL 2025 321
TABLE 404 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 323
TABLE 405 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 324
TABLE 406 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–APRIL 2025 325
TABLE 407 REVVITY: COMPANY OVERVIEW 327
TABLE 408 REVVITY: PRODUCTS OFFERED 328
TABLE 409 REVVITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 329
TABLE 410 SARTORIUS AG: COMPANY OVERVIEW 331
TABLE 411 SARTORIUS AG: PRODUCTS OFFERED 332
TABLE 412 SARTORIUS AG: DEALS, JANUARY 2022–APRIL 2025 333
TABLE 413 NIKON CORPORATION: COMPANY OVERVIEW 334
TABLE 414 NIKON CORPORATION: PRODUCTS OFFERED 335
TABLE 415 NIKON CORPORATION: EXPANSIONS, JANUARY 2022–APRIL 2025 336
TABLE 416 EVIDENT: COMPANY OVERVIEW 337
TABLE 417 EVIDENT: PRODUCTS OFFERED 337
TABLE 418 EVIDENT: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022– APRIL 2025 338
TABLE 419 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 339
TABLE 420 AGILENT TECHNOLOGIES, INC: PRODUCTS OFFERED 340
TABLE 421 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND UPGRADES,
JANUARY 2022–APRIL 2025 342
TABLE 422 NANOENTEK: COMPANY OVERVIEW 343
TABLE 423 NANOENTEK INC.: PRODUCTS OFFERED 343
TABLE 424 BRUKER: COMPANY OVERVIEW 344
TABLE 425 BRUKER: PRODUCTS OFFERED 345
TABLE 426 BRUKER: DEALS, JANUARY 2022–APRIL 2025 346
TABLE 427 BD: COMPANY OVERVIEW 347
TABLE 428 BD: PRODUCTS OFFERED 348
TABLE 429 MERCK KGAA: COMPANY OVERVIEW 349
TABLE 430 MERCK KGAA: PRODUCTS OFFERED 351
TABLE 431 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 352
TABLE 432 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 353
TABLE 433 TECAN TRADING AG: COMPANY OVERVIEW 354
TABLE 434 TECAN TRADING AG: PRODUCTS OFFERED 355
TABLE 435 SYSMEX CORPORATION: COMPANY OVERVIEW 356
TABLE 436 SYSMEX CORPORATION: PRODUCTS OFFERED 357
TABLE 437 CORNING INCORPORATED: COMPANY OVERVIEW 358
TABLE 438 CORNING INCORPORATED: PRODUCTS OFFERED 359
TABLE 439 AXION BIOSYSTEMS, INC.: COMPANY OVERVIEW 360
TABLE 440 BLUE-RAY BIOTECH CORP.: COMPANY OVERVIEW 361
TABLE 441 CURIOSIS INC.: COMPANY OVERVIEW 361
TABLE 442 CYTENA GMBH: COMPANY OVERVIEW 362
TABLE 443 ABBERIOR GMBH: COMPANY OVERVIEW 363
TABLE 444 PHASE HOLOGRAPHIC IMAGING PHI AB: COMPANY OVERVIEW 364
TABLE 445 ALIGNED GENETICS INC.: COMPANY OVERVIEW 365
TABLE 446 CHERRY BIOTECH: COMPANY OVERVIEW 365
TABLE 447 NANOLIVE SA: COMPANY OVERVIEW 366
TABLE 448 CYTOTRONICS: COMPANY OVERVIEW 367
TABLE 449 ETALUMA, INC.: COMPANY OVERVIEW 368
TABLE 450 TISSUEGNOSTICS GMBH: COMPANY OVERVIEW 369

LIST OF FIGURES

FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION 36
FIGURE 2 RESEARCH DESIGN 40
FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 42
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2024 43
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024 44
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER: REVENUE SHARE ANALYSIS, 2024 44
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS 45
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 46
FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2025–2030 47
FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS 48
FIGURE 11 DATA TRIANGULATION METHODOLOGY 49
FIGURE 12 LIVE CELL IMAGING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 52
FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 53
FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 53
FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54
FIGURE 16 LIVE CELL IMAGING MARKET: GEOGRAPHICAL SNAPSHOT 55
FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET 56
FIGURE 18 INSTRUMENTS SEGMENT AND US DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2024 57
FIGURE 19 INSTRUMENTS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030 58
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 58
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN LIVE CELL IMAGING MARKET FROM 2025 TO 2030 59
FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60
FIGURE 23 GLOBAL CANCER INCIDENCE AND MORTALITY, 2022 63
FIGURE 24 REVENUE SHIFT FOR PLAYERS IN LIVE CELL IMAGING MARKET 68
FIGURE 25 AVERAGE SELLING PRICE TREND OF LIVE CELL IMAGING PRODUCTS,
BY KEY PLAYER, 2022–2024 71
FIGURE 26 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 72
FIGURE 27 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS 73
FIGURE 28 LIVE CELL IMAGING MARKET: ECOSYSTEM ANALYSIS 74
FIGURE 29 PATENT ANALYSIS OF LIVE CELL IMAGING MARKET, JANUARY 2014–APRIL 2025 81
FIGURE 30 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 92
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 94
FIGURE 32 KEY BUYING CRITERIA, BY END USER 95
FIGURE 33 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT 202
FIGURE 34 ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT 234
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 293
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 294
FIGURE 37 EV/EBITDA OF KEY PLAYERS, 2025 297
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS, 2025 297
FIGURE 39 LIVE CELL IMAGING MARKET: BRAND/PRODUCT COMPARISON 298
FIGURE 40 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 300
FIGURE 41 LIVE CELL IMAGING MARKET: COMPANY FOOTPRINT 301
FIGURE 42 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 307
FIGURE 43 DANAHER: COMPANY SNAPSHOT (2024) 314
FIGURE 44 ZEISS GROUP: COMPANY SNAPSHOT (2024) 319
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 324
FIGURE 46 REVVITY: COMPANY SNAPSHOT (2024) 328
FIGURE 47 SARTORIUS AG: COMPANY SNAPSHOT (2024) 332
FIGURE 48 NIKON CORPORATION: COMPANY SNAPSHOT (2023) 335
FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 340
FIGURE 50 BRUKER: COMPANY SNAPSHOT (2024) 345
FIGURE 51 BD: COMPANY SNAPSHOT (2024) 348
FIGURE 52 MERCK KGAA: COMPANY SNAPSHOT (2024) 350
FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 353
FIGURE 54 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 355
FIGURE 55 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023) 357
FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2024) 359

---

---